Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.

1992201 citationsJournal Article

Authors

James R. Seibold · Allergy, Asthma and Clinical Research Center

Deborah McCloskey · Allergy, Asthma and Clinical Research Center

William P. Dole · Allergy, Asthma and Clinical Research Center

Abstract

Iloprost appears useful for the treatment of digital ulcers in systemic sclerosis and is associated with evidence of prolonged physiologic improvement although the mechanism of this effect remains unclear.

Topics & Keywords

Systemic Sclerosis and Related Diseases Urticaria and Related Conditions Dermatologic Treatments and Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 19, Issue 9, pp. 1407-14

Field-Weighted Citation Impact: 2.65